Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Greg Monohan | Conditions: Hodgkin's Lymphoma, Multiple Myeloma | Phase 2 | Status: TERMINATED